Global Continuous Glucose Monitoring (CGM) Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Continuous Glucose Monitoring (CGM) Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Component (Transmitters, Sensors, Receivers), Connectivity (Bluetooth, and 4G), End Use (Hospitals, Homecare Settings, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Continuous Glucose Monitoring (CGM) Market was valued at USD 4,643.5 million in 2023 and is expected to reach USD 8,281.5 million by 2031 while growing at a CAGR of 7.5% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global continuous glucose monitoring (CGM) market growth. Continuous glucose monitoring involves employing a device to automatically assess your blood glucose levels around the clock, providing real-time updates. This enables you to monitor your blood glucose levels at any given moment, empowering you to make informed choices regarding your diet, physical activity, and medication intake.
The market for continuous glucose monitoring is propelled by technological advancements that result in the creation of more precise and user-friendly devices, alongside the global increase in diabetes prevalence and growing recognition of the advantages of continuous glucose monitoring in diabetes care. However, hindered growth factors include reimbursement policies for these devices and their high initial costs.
Furthermore, the global continuous glucose monitoring (CGM) industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Component Analysis
The Global Continuous Glucose Monitoring (CGM) Market is segmented among Transmitters, Sensors, Receivers, based on Component. In 2023, Sensors accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Connectivity Analysis
The Global Continuous Glucose Monitoring (CGM) Market is segmented among Bluetooth, and 4G, based on Connectivity. In 2023, Bluetooth accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Continuous Glucose Monitoring (CGM) Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., GlySens Incorporated, Medtronic Plc, Senseonics Holdings, Inc., Medtrum Technologies, Nemaura Medical, Inc, and I-sense.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Continuous Glucose Monitoring (CGM) Market Dynamics
Drivers
Restraints
Opportunity
4. Global Continuous Glucose Monitoring (CGM) Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Continuous Glucose Monitoring (CGM) Market Segmentation, By Component
Global Continuous Glucose Monitoring (CGM) Market Share Analysis, By Component
Global Continuous Glucose Monitoring (CGM) Market Growth Analysis, By Component
Global Continuous Glucose Monitoring (CGM) Market Trends, By Component
o Transmitters
o Sensors
o Receivers
6. Global Continuous Glucose Monitoring (CGM) Market Segmentation, By Connectivity
Global Continuous Glucose Monitoring (CGM) Market Share Analysis, By Connectivity
Global Continuous Glucose Monitoring (CGM) Market Growth Analysis, By Connectivity
Global Continuous Glucose Monitoring (CGM) Market Trends, By Connectivity
o Bluetooth
o 4G
7. Global Continuous Glucose Monitoring (CGM) Market Segmentation, By End User
Global Continuous Glucose Monitoring (CGM) Market Share Analysis, By End User
Global Continuous Glucose Monitoring (CGM) Market Growth Analysis, By End User
Global Continuous Glucose Monitoring (CGM) Market Trends, By End User
o Hospitals
o Homecare Settings
o Others
8. Global Continuous Glucose Monitoring (CGM) Market Segmentation, By Region
Global Continuous Glucose Monitoring (CGM) Market Share Analysis, By Region
Global Continuous Glucose Monitoring (CGM) Market Growth Analysis, By Region
Global Continuous Glucose Monitoring (CGM) Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Abbott Laboratories*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Dexcom, Inc.
A. Menarini Diagnostics
Echo Therapeutics, Inc.
GlySens Incorporated
Medtronic Plc
Senseonics Holdings, Inc.
Medtrum Technologies
Nemaura Medical, Inc
I-sense
*Similar analysis will be provided for each company listed above.
